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Background: Differences in cranial morphology arise due to changes in fundamental cell processes like migration,
proliferation, differentiation and cell death driven by genetic programs. Signaling between fibroblast growth factors
(FGFs) and their receptors (FGFRs) affect these processes during head development and mutations in FGFRs result
in congenital diseases including FGFR-related craniosynostosis syndromes. Current research in model organisms focuses
primarily on how these mutations change cell function local to sutures under the hypothesis that prematurely closing
cranial sutures contribute to skull dysmorphogenesis. Though these studies have provided fundamentally
important information contributing to the understanding of craniosynostosis conditions, knowledge of changes in cell
function local to the sutures leave change in overall three-dimensional cranial morphology largely unexplained. Here
we investigate growth of the skull in two inbred mouse models each carrying one of two gain-of-function mutations
in FGFR2 on neighboring amino acids (S252W and P253R) that in humans cause Apert syndrome, one of the most
severe FGFR-related craniosynostosis syndromes. We examine late embryonic skull development and suture patency in
Fgfr2 Apert syndrome mice between embryonic day 17.5 and birth and quantify the effects of these mutations on 3D
skull morphology, suture patency and growth.
Results: We show in mice what studies in humans can only infer: specific cranial growth deviations occur prenatally
and worsen with time in organisms carrying these FGFR2 mutations. We demonstrate that: 1) distinct skull
morphologies of each mutation group are established by E17.5; 2) cranial suture patency patterns differ between mice
carrying these mutations and their unaffected littermates; 3) the prenatal skull grows differently in each mutation
group; and 4) unique Fgfr2-related cranial morphologies are exacerbated by late embryonic growth patterns.
Conclusions: Our analysis of mutation-driven changes in cranial growth provides a previously missing piece of
knowledge necessary for explaining variation in emergent cranial morphologies and may ultimately be helpful in
managing human cases carrying these same mutations. This information is critical to the understanding of
craniofacial development, disease and evolution and may contribute to the evaluation of incipient therapeutic
strategies.
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Growth of the skull is a complex process that combines
genetic and environmental information to establish and
mineralize the individual bony elements that come to-
gether to protect and support the rapidly expanding soft
tissues of the head, such as the brain [1]. The well-
ordered activity of specific transcription factors regu-
lated by a range of developmental regulatory signals
marks the differentiation of osteoblast lineage cells dur-
ing the ossification process [2]. Among those signaling
systems that pattern growth and assembly of the skull
are fibroblast growth factors (FGF) and their receptors
(FGFRs) whose essential role during development is
largely known through the study of missense mutations
that cause congenital skeletal diseases including cranio-
synostosis, achondrodysplasia, and syndromes with dys-
regulated phosphate metabolism [3,4]. Apert syndrome
[OMIM 101200] is caused by gain-of-function mutations
in FGFR2, over 99% of which are amino acid substi-
tutions in Ser252Trp (S252W) or Pro253Arg (P253R)
[5-7]. Apert syndrome is characterized by premature
fusion of cranial sutures (craniosynostosis), midfacial
retrusion, and additional complex cranial, neural, limb,
and visceral malformations with cognitive ability varying
widely, from normal to severely deficient [8]. FGFR2 is
widely expressed throughout development: therefore
changes in the development of many tissues caused by
these mutations can be observed during embryogenesis,
fetal development, at birth, and post-natally [9,10].
The cranial sutures are major growth sites [11] whose
fusion occurs either upon completion of early, intense
cranial growth or later in life. When sutures close pre-
maturely, specific cranial dysmorphology ensues due in
part to the incapacity for growth perpendicular to the
closed suture. Mutations that cause premature suture
closure occur in genes that are widely expressed through-
out development (e.g., FGFRs). These mutations can
affect growth and development of diverse tissues [9,10]
as the changes in cell signaling initiated by FGFR muta-
tions are not specific to suture mesenchyme and are un-
relenting [12], continuing to affect cellular processes
and tissue-tissue interactions from conception onwards.
Research focused on molecular pathophysiology of pre-
mature suture closure has provided much needed infor-
mation about changes occurring at the subcellular and
cellular level local to the suture mesenchyme, but has
yet to sufficiently elucidate how these changes translate
into the production of more broadly based structural
and functional defects.
In recent years, the study of growth and development
of skeletal tissue has centered on the study of the genetic
control of the temporal sequence of changing osteopro-
genitor cell function (e.g., migration, proliferation, differ-
entiation, apoptosis) providing a baseline understandingof the genetic control of these processes (e.g., [2,13]).
However morphogenesis of skeletal structure occurs via
interactions between cells in multiple tissue layers, in-
cluding physical forces produced by skeletal and soft tis-
sues that can trigger gene expression to regulate gene
function and cell fate. We have previously used precise
3D measures of bone volume, relative bone mineral
density, and skull morphology as a guide towards identi-
fication of the cellular mechanisms responsible for local-
ized differences between mice carrying particular FGFR2
mutations and their unaffected littermates thereby link-
ing particular aspects of dysmorphogenesis to specific
cellular behaviors [14,15]. We have also shown that mu-
tations thought primarily to affect cells of one type (e.g.,
osteoprogenitor) can have equally profound effects on
cells that make up other tissues (e.g., brain, vitreous,
skin) [10,16-18], thereby contributing to tissue-level be-
haviors of morphological development. Advancing our
knowledge of the physical aspects of development re-
quires specification of the direction and magnitude of
changes required to take an initial morphology to a tar-
get shape. Once these architectural details are known,
they can become part of a larger model of computational
tissue biomechanics that more closely specifies the com-
plement of inputs that contribute to the genetic regula-
tion of development and growth. When quantitatively
defined in 3D, growth patterns can be integrated into
models used to predict mutation-specific craniofacial
phenotypes, to test the veracity of therapeutic agents, or
to plan surgical correction.
Prenatal cranial growth patterns are not typically
assessed in humans and because nearly all craniosynos-
tosis patients undergo reconstructive surgery during
infancy, mouse models offer a valuable resource for ad-
dressing the contribution of growth pattern to craniofa-
cial dysmorphogenesis. The premature closure of cranial
vault sutures is thought to contribute to late prenatal
and postnatal dysmorphogenesis, but the precise inter-
action of the mutation-driven changes in cellular pro-
cesses, premature closure of sutures, and growth pattern
is not well understood. Here we provide a comparative
analysis of craniofacial suture closure and growth pat-
tern in two mouse models for Apert syndrome, each car-
rying a mutation in FGFR2 that together account for
99% of all known cases of Apert syndrome. We test the
hypothesis that cranial growth patterns contribute to
cranial dysmorphology in craniosynostosis and demon-
strate that differences in a single mutation change in
neighboring amino acids cause subtle differences in pat-
terns of skull growth. We quantitatively estimate late
prenatal cranial growth patterns and provide a timeline
of cranial suture patency patterns using high resolution
micro computed tomography (HRμCT) images of the
heads of Fgfr2+/S252W and Fgfr2+/P253R Apert syndrome
Figure 1 Landmark and suture placement. Placement of anatomical landmarks (A-D) and sutures (E,F) on E17.5 mouse skull. Views are left
lateral (A), superior (B), inferior (C), endocranial (D), left lateral (E), and inferior (F). Landmarks (A-D) are color coded by region: Face (red); Base
(green); Vault (blue); Palate (orange). Additional landmarks that were used only in analysis of the global skull are shown in black. Sutures (E, F) are
color-coded by region [Face (red); Vault (blue); Palate (orange)] and indicated by number: 1,2) Left, right coronal ; 3, 4) Left, right zygomatic-
maxillary; 5,6) Left, right premaxillary-maxillary; 7) Intermaxillary; 8) Interpalatine; 9) Inter Premaxillary; 10, 11) Left, right maxillary-palatine; 12, 13)
Left, right fronto-maxillary. Sutures 1-6 and 12-13 are bilateral; only left sutures are shown on the left lateral view (E). An additional table provides
more complete definitions of the landmarks, as well as identification of the skull region in which each landmark is located [see Additional file 1].
More information on landmark identification and location can be found at: http://getahead.psu.edu/landmarks_new.html.
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Skull morphology was analyzed at E17.5 and P0 using
anatomical subsets of 3D coordinates of skull landmarks
representing the entire or global skull, the cranial base, the
cranial vault, the facial skeleton, and the palate (Figure 1;
An additional table provides complete information for these
landmarks [see Additional file 1]). All mice were inbred on
C57BL/6 J background to reduce genetic heterogeneity,
allowing direct comparison of the impact of each specific
FGFR2 mutation (see Materials and Methods). Sample sizes
are given in Table 1. Figure 2 provides HRμCT reconstruc-
tions of representative individuals from each sample.E17.5. A principal components analysis (PCA) of form
based on all 528 unique inter-landmark distances esti-
mated from 33 global skull landmarks (Figure 1), was used
as an exploratory first step in describing and comparing
cranial morphologies and growth trajectories [19,20]. A
plot of the first two principal components of E17.5 mice
reveals that cranial morphologies of Fgfr2+/S252W and
Fgfr2+/P253R mice overlap along the first principal com-
ponent axis (PC1) (accounting for 37% of the total vari-
ation in form) and the second axis (PC2) (accounting
for 21% of the variation) (Figure 3A). The distribution
of mutant cranial forms indicates similarity in the gen-
eralized effects of the two mutations on skull shape at
E17.5, although Fgfr2+/S252W cranial morphologies gravitate
farther towards the positive ends of PC1 and PC2. The
distribution of the Fgfr2+/P253R mice along PC1 and PC2
suggests increased variation for this mutation group at
Figure 2 Skull morphology of Fgfr2+/P253R and Fgfr2+/S252W Apert syndrome mice and unaffected littermates at E17.5 and P0. Left
lateral views of 3D HRμCT reconstructions of representative mice from our study samples: Fgfr2+/P253R mutant at E17.5 (A) and P0 (B): unaffected
littermate of the P253R model at E17.5 (C) and P0 (D); Fgfr2+/S252W mutant at E17.5 (E) and P0 (F); unaffected littermate of the S252W model at
E17.5 (G) and P0 (H). By P0, midfacial retrusion is more severe and fusion of multiple sutures is apparent.
Table 1 Samples sizes of Fgfr2+/S252W and Fgfr2+/P253R Apert mouse models and unaffected littermates (listed to the left
of each model) at embryonic day 17.5 (E17.5) and day of birth (P0)
Age
E17.5 P0
Fgfr2+/+ Fgfr2+/S252W Fgfr2+/+ Fgfr2+/P253R Fgfr2+/+ Fgfr2+/S252W Fgfr2+/+ Fgfr2+/P253R
11 10 12 12 25 23 28 36
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Figure 3 Principal Components Analysis of form and shape at
E17.5. A) Placement of all E17.5 mouse crania on PC1 and PC2 in
the skull form space (as estimated by principal component analysis
of all possible linear distances among cranial 33 landmarks on all
E17.5 mice). B) Placement of all E17.5 mouse crania on PC1 and PC2
in the skull shape space (as estimated by principal component
analysis of all possible linear distances of each observation, scaled by
the observation’s geometric mean).
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Fgfr2+/P253R Apert syndrome mice and their unaffected
littermates is seen along PC2. Cranial morphologies of
both sets of unaffected littermates show overlap along
PC1 and PC2.
To consider the relative amount of variation attributable
to shape alone (i.e., without variation due to size) among the
E17.5 animals, the PCA was repeated using the linear dis-
tances of each observation scaled by the observation’s geo-
metric mean [19,21,22] (Figure 3B). The PCA of the scale-
free shape data maintained the separation between mutant
and unaffected mice, but only slightly reduced the amount
of within-group variation, suggesting that at E17.5, differ-
ences in scale do not greatly contribute to form differences
between Fgfr2 mutant and unaffected littermates or to the
differences between Fgfr2+/S252W and Fgfr2+/P253R mice.The 3D patterns of shape difference between the
Fgfr2+/S252W and Fgfr2+/P253R Apert syndrome mouse models
and their unaffected littermates at E17.5 were evaluated
using Euclidean Distance Matrix Analysis (EDMA) [23-25]
(see Methods). The null hypothesis test of similarity in shape
between Fgfr2 mutant mice and unaffected littermates pro-
vide an initial evaluation of form differences between mutant
mice and unaffected littermates. An additional table file
provides the results of these hypothesis tests [see Additional
file 2]. Estimates of localized differences and evaluation of
the statistical uncertainty of these estimates are contained
within bootstrapped confidence intervals discussed below.
Confidence intervals for local effects of the two Fgfr2
Apert syndrome mutations at E17.5 reveal differential
characteristics of mutation-driven shape change. Most
notable is the overall reduction in the more rostral ele-
ments of the skull in Fgfr2+/S252W mice relative to un-
affected littermates (Figure 4A, B), especially in the
premaxillae, the posterior aspect of the palate, and dimen-
sions that connect the premaxillae with the rostral cranial
base. An additional movie file provides a 3D view of these
differences [see Additional file 3]. In contrast, Fgfr2+/P253R
mice show localized increases in posterior facial dimensions
relative to unaffected littermates (Figure 4E, F). An add-
itional movie file provides a 3D view of these differences
[see Additional file 4]. Both models show a rostrocaudal re-
duction across the basioccipital synchondrosis, coupled with
increasing distances between the rostral aspect of the
basioccipital and the pterygoid processes. Fgfr2+/P253R mice
show an increase in distances between the frontal process of
the maxilla and the palate relative to unaffected littermates
(Figure 4E, F), which is unique to this mutation. A relative
increase in width of the caudal cranial vault is seen in both
models (Figure 4B, F). Fgfr2+/P253R mice also show an in-
crease in caudal cranial vault height (Figure 4E).
P0. At P0, Fgfr2+/S252W (Figure 4C, D) and Fgfr2+/P253R
(Figure 4G, H) mutant mice demonstrate statistically signifi-
cant differences in global shape and in the shapes of all ana-
tomical subsets relative to their respective littermates
[Additional file 2]. A four to five-fold increase in the number
of significant differences of local cranial measures are
present at P0 relative to what is estimated for morphological
differences at E17.5. Additional movie files provide a 3D
view of these differences [see Additional files 5 and 6]. De-
tails of the specific differences in the anatomical effects of
the two Apert syndrome mutations at P0 were previously
described [14,26-28] and differ from those described for
E17.5. At P0, differences between mutant mice and their un-
affected littermates occur across the entire skull but the fa-
cial skeleton is the most affected region, with Fgfr2+/S252W
mutant mice displaying significantly more severe dysmor-
phology localized to the posterior palate [14,26]. Coronal
suture patency was not strongly correlated with skull dys-
morphology at P0 in either Fgfr2 mutant.
Figure 4 Morphological variation at E17.5. Differences in morphology between Fgfr2+/S252W mice and unaffected littermates at E17.5 (A, lateral
view; B, superior view) and P0 (C, lateral view; D, superior view) and between Fgfr2+/P253R mice and unaffected littermates at E17.5 (E, F) and P0
(G, H). For all views rostral is left, caudal is right. The linear distances pictured are limited to those that differed significantly by ≥ 5% between
mice carrying one of the two Fgfr2 mutations and their respective unaffected littermates (using α = 0.10 confidence limits). The magnitude of
these differences varies across the skull. Lines represent distances among landmarks that are significantly larger (blue) and significantly smaller
(fuchsia) in mutant mice. Thin lines indicate linear distances that are increased/decreased by 5-10% in mice carrying one of the two Fgfr2 muta-
tions while thick lines indicate linear distances that differ by >10% between unaffected and mutant mice. Bone segmented from HRμCT images is
shown as partially transparent to better visualize the differences. See supplementary videos for a full 360-degree rotation view of differences in
cranial morphology between Fgfr2+/S252W mice and unaffected littermates at E17.5 [Additional file 3] and P0 [Additional file 5], and differences in
cranial morphology between Fgfr2+/P253R and unaffected littermates at E17.5 [Additional file 4] and P0 [Additional file 6].
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Principal components analyses of ontogenetic variation in
skull form (see Methods) revealed that skull morphology
of mice carrying the Fgfr2 S252W and P253R mutations
cluster near one another at both E17.5 and P0, clearly
separated from their age-matched unaffected littermates
(Figure 5A). PC1 (accounting for 77% of variation in
form) primarily reveals the impact of developmental
age, with the skulls of all E17.5 mice gravitating towards
the negative end of PC1, and the older mice situated at
the positive end (Figure 5A). PC2 (accounting for ~8%
of the variation in craniofacial form) separates groups
according to whether or not group members carry one
of the two Fgfr2 mutations. Although the morphological
consequences of developmental age convey a strong sig-
nal during late embryogenesis (characterized by PC1),
the impact of carrying one of the two Fgfr2 mutations is
also apparent at E17.5 and at P0 (characterized by PC2).
An alternate way to consider the relative amount of
variation in shape among the ontogenetic samples is to re-
peat the PCA analysis using linear distances for each ob-
servation scaled by their respective geometric mean (see
Methods). Separation of groups is maintained in the ana-
lysis of skull shape, though the distance among groups is
decreased, emphasizing both the substantial contribution
of size-related changes in shape to variation produced by
growth and the distinct patterns of dysmorphogenesis as-
sociated with these Fgfr2 mutations (Figure 5B). Distinc-
tion among groups defined on the basis of developmental
age is delineated primarily along PC1 (accounting for ~33%of variation in shape), but an equally clear separation
among skull shapes defined by the presence/absence of an
Fgfr2 mutation is revealed along PC2 (~27% of variation in
shape), indicating that a substantial proportion of variation
in skull shape is a consequence of carrying one of the two
Fgfr2 mutations. Approximately one-third of the overall
variation is due to shape alone, as calculated by the ratio of
the sum-of-variances for ln-transformed ratios of distances
to their geometric mean (1.18) to the sum-of-variances for
ln-transformed distances among all landmarks (3.75) - a re-
markable amount given that data from two age groups
comprise substantial differences in overall size [19,21]. Re-
gardless of whether cranial form (Figure 5A) or cranial
shape (Figure 5B) is considered, distinction between the
Fgfr2+/P253R and Fgfr2+/S252W Apert syndrome mice cra-
nial morphologies is not apparent at E17.5, but the two
mutation groups are fairly well-discriminated at P0.
Growth difference of Apert syndrome Fgfr2+/S252W and
Fgfr2+/P253R mice
We quantify growth as the process that changes the config-
uration (size and shape) of a mouse skull at E17.5 to its
configuration at P0 and statistically evaluate differences
in growth among groups using Growth Difference Matrix
Analysis (GDMA) (see Methods). Within each model for
Apert syndrome, mice carrying an Fgfr2 mutation exhibited
statistically significant differences in late prenatal skull
growth relative to unaffected littermates for most of the
craniofacial regions. An additional table provides the results
of these hypothesis tests [see Additional file 7]. Confidence
Figure 5 Principal Components Analysis of form and shape:
E17.5 and P0 data combined. A) Placement of E17.5 and P0 mouse
crania on PC1 and PC2 in the skull form space as estimated by principal
component analysis of all linear distances among 33 cranial landmarks. B)
Placement of the all E17.5 and P0 mouse crania on PC1 and PC2 in the
skull shape space (as estimated by principal component analysis of all
possible linear distances scaled by the age and genotype-specific geomet-
ric sample mean) among cranial 33 landmarks on all E17.5 and P0 mice.
Motch Perrine et al. BMC Developmental Biology 2014, 14:8 Page 7 of 16
http://www.biomedcentral.com/1471-213X/14/8intervals testing reveal statistically significant differences in
growth of the majority of linear distances measured among
landmarks. Relative to unaffected littermates, Fgfr2+/S252W
and Fgfr2+/P253R Apert syndrome mice both display de-
creased magnitudes of growth in most rostrocaudal dimen-
sions crossing the premaxillae and the maxillary palatal
shelves (Figure 6). Additional movie files show these growth
differences in 3D [see Additional file 8 for 3D view of differ-
ences in growth between Fgfr2+/S252W mice and unaffected
littermates and Additional file 9 for 3D view of differences
in growth between Fgfr2+/P253R mice and unaffected litter-
mates]. Growth is also diminished along distances between
the most dorsal extension of the frontal process of the max-
illae and points on the rostral cranial base and palate in
both models contributing to a facial skeleton in mutant
mice that is generally narrowed, flattened and reducedin height. Relative to unaffected littermates, growth is
increased in distances between the ethmoid and the
premaxillary-maxillary suture (Figure 6B, D). The
relative increase in mediolateral growth of the cra-
nial base and neurocranium seen in Fgfr2+/S252W
mice (Figure 6A,B; Additional file 8) does not occur
in Fgfr2+/P253R mice (Figure 6C,D; Additional file 9).
Relative to unaffected littermates, both models ex-
perience increased growth of the caudal cranial base
along a rostrocaudal axis.
The most caudal aspect of the palate has been previ-
ously identified as a site of localized dysmorphology in
Fgfr2+/S252W and Fgfr2+/P253R Apert syndrome mice, as
well as a region where the morphological effects and lo-
calized cellular processes of the two Fgfr2 mutations can
be differentiated [14]. Hypothesis tests of similarity in
growth show that palatal growth patterns are different
from unaffected mice in both Apert syndrome models.
Direct comparison of palatal growth between Fgfr2+/S252W
and Fgfr2+/P253R Apert syndrome mice revealed high vari-
ability in palatal growth for each model. As a result, even
though the magnitude of growth of some palatal dimen-
sions were dissimilar between the two models, the differ-
ences were not significant (Additional file 2). Compared to
unaffected littermates, differences in growth are strongest
at the caudal aspect of the pterygoid plates in both models.
Relative to unaffected littermates, magnitudes of late
prenatal growth of the cranial base in Fgfr2+/S252W Apert
syndrome mutant mice are significantly increased along
mediolateral dimensions. Only the increased mediolateral
growth of the basi-sphenoid synchondrosis is shared with
Fgfr2+/P253R Apert syndrome mice; the other local changes
in cranial base growth are specific to the FGFR2 S252W
mutation (Figure 6). Differences in growth of the cranial
vault are minimal between Fgfr2+/S252W and Fgfr2+/P253R
Apert syndrome mice and their unaffected littermates
(Figure 6).
Estimation and evaluation of hypothetical forms
Differences in cranial morphology among our samples at
P0 are due to the combination of altered morphology at
E17.5 and distinct growth patterns for each genotype
group. The production of hypothetical forms and their
evaluation with respect to samples of known morpholo-
gies [24,29] provide an alternate approach to the evalu-
ation of the contribution of growth pattern to craniofacial
phenotypes. The hypothetical forms in this case embody
the 3D morphology of an unaffected mouse cranium at
E17.5 and the growth pattern estimated for mice carrying
one of the two Fgfr2 mutations. The 3D coordinates of the
two hypothetical crania (A: the average cranial morph-
ology of an unaffected littermate at E17.5 grown using the
Fgfr2+/S252W mutant growth pattern; and B: the average
cranial morphology of an unaffected littermate at E17.5
Figure 6 Variation in growth of Apert syndrome models. Differences in growth between Fgfr2+/S252W and unaffected littermates (A, lateral
view; B, superior view) and Fgfr2+/P253R and unaffected littermates (C, lateral; D, superior). For all views rostral is left, caudal is right. The linear
distances pictured are limited to those whose growth from E17.5 to P0 differed significantly by ≥ 5% using α = 0.10 confidence limits. The
magnitude of these differences in growth varies across the skull. Linear distances that grew significantly more (blue) and significantly less (white)
in mutant mice are shown. Thin lines indicate linear distances whose growth was increased or decreased by 5-10% in mice carrying one of the
two Fgfr2 mutations relative to their respective unaffected littermates; thick lines indicate linear distances whose growth differed by >10%
between unaffected and mutant mice. Bone segmented from HRμCT images is shown as partially transparent to better visualize the growth
differences. See supplementary videos for a full 360-degree rotation of differences in cranial growth between Fgfr2+/S252W mice and
unaffected littermates [Additional file 8] and between Fgfr2+/P253R and unaffected littermates [Additional file 9].
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added to our samples and analyzed using PCA. Because
the simulated morphologies (Hypothetical forms A and B)
and the unaffected mice share the same initial morpholo-
gies at E17.5, any differences observed between the hypo-
thetical forms and unaffected P0 mice can be attributed
exclusively to differences in growth caused by the presence
of an Fgfr2 mutation.
PCA is used to visualize differences in growth trajector-
ies (Figure 7) previously shown by GDMA to be statis-
tically different between mutant and unaffected groups.
Neither hypothetical form falls within the concentration
of unaffected P0 cranial morphologies, revealing the con-
tribution of abnormal prenatal growth pattern to the mor-
phological differences between genotypes at birth. The
position of the two hypothetical forms suggests that the
Fgfr2+/S252W mutation provides a relatively stronger con-
tribution to dysmorphogenesis.
Patterns of suture patency
Current theories state that when premature fusion of
cranial vault sutures occur, secondary distortion of skull
shape results in part from the lack of growth perpen-
dicular to the fused suture and compensatory over-
growth at the non-fused sutures [30]. To test whether
these same principles apply to sutures of the facialskeleton we scored patterns of suture patency as visual-
ized on HRμCT images of each mouse assigning qualita-
tive scores of open, partially open, or fused to the entire
length of the sutures (Figure 8A). These observations
were used to build a comparative timeline of suture clos-
ure in all groups of mice (Figure 8B).
We previously demonstrated a higher percentage of
Fgfr2+/S252W mice with complete (69%) bicoronal synos-
tosis at P0 compared to Fgfr2+/P253R mice [26]. At E17.5,
variable levels of coronal suture fusion are seen in both
Apert syndrome models (Figure 8A, columns 1,2) al-
though neither displays completely fused coronal sutures,
indicating that premature fusion of coronal sutures is
well underway at E17.5 and are nearing complete fusion
by P0 [26]. The zygomatic-maxillary and premaxilla-
maxillary sutures are invariably fused in Fgfr2+/S252W
and Fgfr2+/P253R mutant mice at P0, while these sutures
are consistently patent (at least partially) in unaffected P0
littermates (Figure 8A, columns 3,4,5,6). No fusion of the
zygomatic-maxillary sutures is seen in Fgfr2+/S252W mutant
mice at E17.5, but unilateral and bilateral partial fusion
is seen in small numbers of Fgfr2+/P253R mutant mice at
E17.5 (Figure 8A, columns 3,4). A majority (85%) of
Fgfr2+/P253R and Fgfr2+/S252W mutant mice show bilat-
eral partial fusion of the premaxilla-maxillary suture at
E17.5 while these sutures are fully patent in unaffected
Figure 7 Mouse cranial in the skull form space. Placement of all
mouse crania on PC1 and PC2 in the skull form space estimated by
PCA of all unique linear distances among 33 cranial landmarks (on all
mice including two hypothetical forms) to show the estimated growth
trajectory for each sample as vectors. GDMA revealed growth patterns
between mutant mice and unaffected littermates to be statistically
different (Figure 6; Additional file 7). Group-specific mean vectors begin
at the location of the E17.5 group mean form in the skull form space
defined by the PCA and end at the location of the P0 group-specific
mean form. Hypothetical form A represents the average Fgfr2+/+
(S252W) cranial morphology grown using the Fgfr2+/S252W growth
pattern. Hypothetical form B represents the average Fgfr2+/+ (P253R)
cranial morphology grown using the Fgfr2+/P253R growth pattern. The
growth trajectories for the hypothetical forms (ghosted) begin at the
group-specific unaffected E17.5 mean and are equivalent in direction
and magnitude to the growth trajectories of the mutant mice, ending
at the position of the hypothetical forms (see text).
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http://www.biomedcentral.com/1471-213X/14/8littermates (Figure 8A, columns 5,6). The maxillary-
palatine sutures are patent in all animals at E17.5 but
show variable patterns of fusion at P0 (Figure 8A, col-
umns 10,11). The fronto-maxillary sutures show a con-
sistent tendency towards fusion in Fgfr2+/S252W and
Fgfr2+/P253R mice at P0 (Figure 8A, columns 12,13), but
remain completely patent in unaffected littermates.
Most midline palatal sutures (Figure 8A, columns 7,8,9)
are patent in all mice at E17.5, but the interpremaxillary
suture reveals a tendency towards fusion in unaffected
mice beginning at E17.5 and continuing to P0 (Figure 8A,
column 9).
To explore the possibility that compensatory growth
driven by the premature closure of facial sutures drives
craniofacial dysmorphology, we examined the relation-
ship between facial suture closure patterns and growth
related cranial shape variation. States of facial suture pa-
tency (open, partially closed, closed) coded for individual
mice were plotted on the basis of differences in skull
shape as quantified by PCA (Figure 9). The average con-
dition of all facial sutures estimated for each mouse re-
veals a strong relationship between facial suture patencyand intensity of craniofacial dysmorphology (Figure 9B)
while the relationship between patency of individual fa-
cial sutures and cranial shape variation (Figures 9C-H)
reveals local patterns. Closing or closed bilateral facial
sutures are always associated with increased facial dys-
morphology as defined by PC2 (Figure 9C-E), while the
relationship between midline sutures (that show varying
patterns of patency) and facial dysmorphology is less
clear. The abnormally patent interpremaxillary suture in
mutant mice (Figure 9F) enables compensatory medio-
lateral facial growth not possible in unaffected mice.
Discussion
Although the specific changes in craniofacial shape and
the magnitude and direction of 3D cranial growth pat-
terns in mice do not coincide exactly with those of hu-
man beings, our results agree with observations of infant
Apert syndrome phenotypes. In humans, Apert syn-
drome cases carrying the FGFR2 S252W mutation have
a more severe facial phenotype relative to those who
carry the FGFR2 P253R mutation, while the FGFR2
P253R group has more severe limb anomalies [5,31,32].
These craniofacial findings have recently been confirmed
quantitatively in a study of craniofacial phenotypes in
FGFR-related craniosynostosis syndromes [33]. Our ana-
lysis concurs with these observations of the differential
effects of the two Apert syndrome mutations revealing
that mice carrying the Fgfr2S252W mutation typically
have a more severe facial phenotype and a growth pat-
tern that contributes to the increased intensity of facial
dysmorphology relative to mice carrying the Fgfr2P253R
mutation.
Mutation-driven differences in growth patterns concur
with the observations that growth modification in Apert
syndrome has its onset prenatally [34,35], and that dys-
morphology increases in severity with age, producing
additional complications [36]. Because of the continual
contribution of FGF/FGFR signaling to cell processes
that direct the assembly and growth of diverse cranial
tissues, FGFR mutations affect growth patterns in unpre-
dictable ways. Individuals born with Apert syndrome in-
variably face multiple complex surgeries that begin in
infancy and continue through adulthood. The functional
and cosmetic outcomes of these procedures cannot be
anticipated in detail and the strategy and number of
these surgeries are typically tailored to the individual.
We have provided evidence that variation in the causative
mutation, the severity of disease phenotypes, and the
changes that occur with growth of the craniofacial
complex might be significant contributing factors to the
uncertainty of long-term surgical outcome. Individual
phenotypes result from change(s) in specific (and poten-
tially diverse) signalling and regulatory cascades, and these
changes have consequences for development of various
Figure 8 Craniofacial suture patency in Fgfr2+/S252W and Fgfr2+/P253R mice and unaffected littermates visualized by HRμCT. A) Patent
sutures are green, partially patent (closing) sutures are yellow, and sutures that are no longer patent (closed) are blue. Suture identification is
along the X-axis while the percent of individuals within a sample showing a patency state is given on the Y-axis. Numeric codes for the sutures:
1, 2 – Left, right coronal; 3, 4 – Left, right zygomatic-maxillary; 5,6 – Left, right premaxillary-maxillary; 7 - Intermaxillary; 8 - Interpalatine; 9 - Inter
premaxillary; 10, 11 – Left, right maxillary-palatine; 12,13 – Left, right fronto-maxillary. Suture locations are shown in Figures 1 and 8B. Only coronal
suture patency was recorded for the neurocranium as all other neurocranial sutures were patent in all animals at these ages. The internasal suture
was patent in all mice. B) Timeline of cranial suture closure based on data from E17.5 and P0 mice. Colors used on trajectories between the
observed time points are interpolated. Arrows at the end of trajectories indicate that the status observed at P0 is ongoing. Trajectories without an
arrow suggest that future suture patency states could not be interpolated from available data. Suture patency patterns were similar across
unaffected littermates so data were pooled.
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Figure 9 Relationship of suture patency patterns and craniofacial shape as estimated by PCA. (A) Distribution of all individuals along PC1
and PC2 following Figure 5A. (see Figure 5A and Methods for details of computing the PCA). (B) Distribution of individuals along PC1 and PC2
coded by the average patency of all facial sutures (coronal suture patency is not included in this average); (C-H) Distribution of individuals along
PC1 and PC2 coded for patency of: zygomatic-maxillary suture (C); frontomaxillary suture (D); premaxillary-maxillary suture (E); inter-premaxillary
suture (F); inter-maxillary suture (G); inter-palatine suture (H).
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definition of growth patterns, the ability to anticipate these
trajectories, and the use of evidence-based growth simula-
tion in patient care could contribute to improved patient-
centered outcomes either through changes in surgical ap-
proach, or through more realistic modeling and expect-
ation of surgical outcome. Our results indicate that
growth pattern is an additional source for observed
phenotypic differences among patients carrying these dif-
fering Apert syndrome mutations and suggest that devel-
oped therapies need to specifically target the mutation
rather than being generally adapted to the disease.
Previous work with mouse models has revealed that
tissues other than bone are affected by Fgfr2 mutations[10,16] and that early postnatal growth patterns of the
brain and skull in Fgfr2+/P253R Apert syndrome mice dif-
fer from their unaffected littermates [37]. The impact of
growth pattern on emergent prenatal morphology quan-
tified here is suggestive of the combination of two ori-
gins of growth insult: 1) mutation-driven disruption of
early cellular processes (e.g., cell migration, proliferation,
differentiation) resulting in the initial construction of ab-
normal phenotypes; coupled with 2) the impact of the mu-
tation on additional cellular processes and tissue-tissue
interactions resulting in changes in functional pressures
and exchanges among growing tissues, changes often con-
sidered secondary to the direct mutational effects. Early
closure of facial sutures, a direct result of disrupted
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growth but due to the comparative abundance of sutures
within the facial skeleton, the ‘compensatory growth’
model described in the case of prematurely closed vault
sutures [38] is not easily translated to facial growth pat-
terns in craniosynostosis syndromes.
Suture formation, patency and eventual closure occurs
through coordinated integration of signaling pathways
(e.g., FGF, TGFβ, Wnt) via processes that are not currently
understood. Our inability to identify the physiological
trigger that elicits premature suture closure indicates that
the molecular instructions for this event and for suture
closure in typical cases occur well within hierarchies of in-
teractions that involve genes carrying identified mutations.
Premature closure of sutures is an example of “tinkering”
[39] of the evolutionarily stable, generic suture fusion
event, though patency/closure of each suture may be su-
pervised by subtly different change(s) in specific regulatory
cascades. Vault and facial suture patency may be sensitive
to similar or different signaling families, to variation in the
strength or timing of signals, or to shifts in patterning
boundaries. Changes in patency patterns can have mul-
tiple consequences for phenotypic variation.
Evolutionarily, sutures are recognized as much for their
role in mediating cranial mechanics as for their contribu-
tion to bone growth [40]. Vertebrate evolution reveals a
general trend of reduced cranial kinesis through the loss
or restriction of some intracranial joints (sutures) and re-
duction in the number of jaw and skull bones (and con-
currently the number of sutures) [41], which is strongly
associated with changes in cranial morphology. Though it
is not possible to record changes in rates of suture closure
across evolutionary time scales, our systematic record of
differences in relative rates of suture closure in mutant
and typically developing mice strongly suggests a role for
variation in the relative rates of suture closure (and
growth at sutures) in generating phenotypic variability in
craniofacial shape over evolutionary time.
Evidence presented here of the local and global aspects
of 3D growth patterns that contribute to craniofacial
morphogenesis provides a layer of information rarely quan-
tified in the dissection of mutational effects on phenotypes.
Current research paradigms focused on the mechanistic
basis of premature suture closure reveal highly localized
effects of activating mutations (e.g., [14,27,28,42-44]), but
these effects vary by suture (and even by location within
the suture) and time of development. In the case of FGFR-
related craniosynostosis syndromes, FGFR mutations
affect many tissues throughout development [10]. Local
patterns of signaling are dynamic, continually changing in
intensity and temporo-spatial distribution such that
current methods of histological and immunohistochemical
observation can provide only a limited sampling of data
required to predict morphology. Because of the continualcontribution of FGF/FGFR signaling to cell processes that
direct the assembly and growth of diverse cranial tissues,
FGFR mutations affect growth patterns in ways that are
currently unpredictable. Groups of cells, tissues and or-
gans respond to the mutant signal by changing their be-
havior according to the aberrant instruction, but must
simultaneously adjust behaviors in response to the signals
emanating from functional pressures of surrounding cells
and tissues, including the shifting constraints caused by
prematurely closing sutures. Complex combinations of
molecular, cellular and biomechanical information under-
lying patterns of accommodation of developing structures
constitute the growth pattern. Combining precise know-
ledge of mutation-induced changes in growth pattern with
geometric information of local patterns of changes in sig-
naling and cell function using a multiscale computational
network approach can contribute to models of develop-
mental tissue mechanics bringing us closer to modeling
testable hypotheses of the morphogenetic unfolding of
genetic programs during ontogeny.Conclusions
Our results demonstrate that the differential effects of
the FGFR2 S252W and P253R mutations result in
mutation-specific prenatal cranial growth patterns that
are responsible, at least in part, for differences in postna-
tal cranial phenotypes of the two mutation groups. We
have demonstrated that the two gain-of-function muta-
tions in FGFR2 uniquely perturb prenatal cranial growth
patterns and cause differences in suture patency and cra-
niofacial dysmorphology that can be quantitatively dis-
tinguished as early as E17.5. Within each mutation
group, the cranial features that are divergent between
mutant and unaffected littermates at E17.5 are not the
same features that are divergent at P0. Further, the pat-
terns of growth suggest that dysmorphologies become
increasingly different with age. Finally, regardless of ini-
tial morphology, we demonstrate how precise 3D esti-
mates of changes in the growth pattern caused by the
presence of either of these two Fgfr2 mutations contrib-
ute to the production of craniofacial dysmorphology.
Our findings suggest that direct and indirect effects of
a mutation need to be considered when determining the
production of craniofacial morphology. Individual vari-
ation in FGFR signal strength and response-to-signal
contribute to osteoprogenitor cell differentiation, bone
deposition, and the premature fusion of sutures, but
physical accommodations of changing structures over
time also participate and contribute to signaling cas-
cades that are part of cranial morphogenesis. Any pro-
posed therapeutic strategy that targets cellular processes
local to a site of altered development (e.g., a suture)
should be evaluated in terms of the effects of that
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of local changes in cell dynamics on growth of the over-
all cranial assembly. Although our results specifically
address disease-causing FGFR2 mutations demonstrat-
ing the relevance of altered growth pattern to the pro-
duction of FGFR-associated dysmorphogenesis, this
approach can be applied to other murine disease models
and to human data when available.
Methods
Generation of targeting construct and Apert FGFR2
mouse models
Our sample consists of Fgfr2+/S252W and Fgfr2+/P253R
Apert syndrome mouse models and their unaffected lit-
termates (Table 1), generated at Johns Hopkins Medical
Institutions and Mount Sinai Medical Center [27,28].
Both knock-in mouse models have been back-crossed
onto the same genetic C57BL/6J background for more
than ten generations, allowing direct comparison be-
tween models. Embryos harvested at E17.5 and P0 mice
were euthanized by inhalation anesthetics and fixed in
4% paraformaldehyde. Gestation time was 19.0 ± 0.5 days.
Genotyping of tail DNA by PCR was performed to dis-
tinguish mutant from unaffected littermates [27,28].
Mouse litters were produced, sacrificed and processed in
compliance with animal welfare guidelines approved by
the Johns Hopkins University, the Mount Sinai Medical
Center and the Pennsylvania State University Animal
Care and Use Committees.
Image acquisition and landmark data collection protocols
Our sample contained 112 P0 mice and 45 E17.5 em-
bryos (Table 1). High-resolution micro-computed tom-
ography (HRμCT) images with pixel size and slice
thickness ranging from 0.014 to 0.025 mm were ac-
quired by the Center for Quantitative X-Ray Imaging
at the Pennsylvania State University (www.cqi.psu.edu)
using the HD-600 OMNI-X high-resolution X-ray com-
puted tomography system (Bio-Imaging Research Inc,
Lincolnshire, IL). Image data were reconstructed on a
1024 x 1024 pixel grid as a 16-bit TIFF but were reduced
to 8-bit for image analysis. Isosurfaces were recon-
structed to represent all cranial bone at P0 or E17.5 based
on hydroxyapatite phantoms imaged with the specimens
using the software package Avizo 6.3 (Visualization Sci-
ences Group, VSG). The minimum thresholds used to
create the isosurfaces ranged from 70-100 mg/cm3 par-
tial density hydroxyapatite. A set of 33 three-dimensional
(3D) landmarks describing the global skull (Figure 1;
Additional file 1) was collected from the isosurfaces. Each
specimen was digitized twice by the same observer and
measurement error was minimized by averaging the coor-
dinates of the two trials. The maximum accepted error in
landmark placement was 0.05mm.Statistical evaluation of shape and growth differences
Comparison of morphologies
Principal components analysis of form and shape.
Ontogenetic variation in skull shape was initially assessed
using principal components analysis (PCA), an approach
that summarizes the variation of a large number of vari-
ables (528 unique interlandmark distances estimated
from 33 landmarks representing the global skull for each
individual) in a lower-dimensional space. The low-
dimensional space is defined by principal components
axes, which are mutually-orthogonal, linear combina-
tions of the measurement data. The scores of an obser-
vation along the principal axes map that observation
into the space. When ontogenetic samples are consid-
ered, growth trajectories can be visualized and compared
by plotting the scores along two or more principal axes.
Two types of PCA were carried out: a PCA based on
variation in form (size and shape together), followed by
a PCA based on shape variation alone [19,21,22]. For
form, all of the inter-landmark distances were ln-trans-
formed and their variance-covariance matrix was used
as the basis for the PCA. For shape alone, the linear
measures were used to define dimensionless shape vari-
ables, where all information about the absolute size of
the measurements was removed and only information
about proportions remained. The shape variables for an
observation were defined as the ln-transformed ratios of
its linear distances to the geometric mean of all of its
distances (where the geometric mean serves as a meas-
ure of overall size). As with the PCA for form, the PCA
for shape was based on the variance-covariance matrix.
When using these definitions, the amount of overall
variance in form can be partitioned into the proportion
that is due to form (size and shape) variation and the
proportion that is due to variation in shape alone [19].
The amount of variation due to form (size and shape) is
the sum of variances for all of the ln-transformed linear
measurements, while the amount of variance due to
shape alone is the sum of variances for the ln-trans-
formed ratios. The difference in these is the amount of
variance due to size alone. All principal components
analyses were performed using SAS 9.3 (SAS Institute,
Cary, NC).
Confidence intervals for differences in form. The glo-
bal skull was defined by the 3D coordinates of the 33
landmarks with subsets of these landmarks used to de-
fine the face, cranial vault, cranial base and palate (Fig-
ure 1, Additional file 1). We used Euclidean Distance
Matrix Analysis (EDMA; [24]) to statistically evaluate
shape differences between samples of mutant mice and
unaffected littermates as well as to assess differences in
growth patterns. EDMA is a 3D morphometric technique
that is invariant to the group of transformations consisting
of translation, rotation, and reflection [23,29]. Briefly, the
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ing the forms are re-written and analyzed as a matrix of
all unique linear distances among landmarks called the
form matrix or FM. An average FM is estimated for each
sample following [24]. The form difference between sam-
ples is evaluated by calculating ratios of like-linear dis-
tances using the average FMs of the two samples. The
resulting matrix of ratios, the form difference matrix
(FDM), represents the collection of relative differences
among the distances used to define the forms. A non-
parametric bootstrap procedure is used to obtain confi-
dence intervals for elements (each corresponding to a lin-
ear distance) of the FDM [23,24]. Confidence interval
testing reveals the localized effects of the mutations
on the craniofacial skeleton. We also include a non-
parametric statistical test of the null hypothesis of similar-
ity in form between the samples for 3D landmark datasets
representing both the entire (global) skull and anatomical
sub-regions (face, cranial vault, cranial base, palate)[see
Additional file 2]. For each group of landmarks represent-
ing regions of the skull, an FDM is estimated. The ratio of
the maximum entry of the FDM to the minimum entry
(maximum ratio of inter-landmark distances divided by
minimum ratio, or max/min) serves as a test statistic
measuring the degree of difference between forms. It is
evaluated using a non-parametric bootstrap (100,000
resamples) to assess the null hypothesis that the mean
form of the two samples is the same [24]. If max/min falls
in the extreme right-hand tail of the null distribution, we
reject the null hypothesis at the appropriate level of sig-
nificance. We report the p-values in Additional file 2. Note
that even when the hypothesis of similarity in form for a
cranial region cannot be rejected, confidence intervals
may indicate specific linear distances that are statistically
different between the samples under investigation reveal-
ing highly localized significant differences between
samples. All EDMA analyses were performed using
EDMAware [45].
Statistical comparison of growth patterns
Because size and shape are inextricably linked in growth,
we adopt a methodology for the quantitative analysis of
growth patterns that moves the analysis of growth to the
3D form space of biological objects using growth differ-
ence matrix analysis (GDMA), to statistically compare
growth patterns following [24,29]. As described for the
comparison of forms (above), 3D landmark locations are
used to estimate a FM for two samples (here represent-
ing different age groups), and ratios of like linear dis-
tances are used to estimate the relative changes in
geometry that occur due to growth. To estimate the
growth matrix, or GM for each group, the FM of the
newborn mouse serves as the numerator and the FM of
the E17.5 sample serves as the denominator, and ratiosare estimated element-wise. In our application, a GM is
calculated within each genotype group (Fgfr2+/P253R
mice; P253R unaffected littermates; Fgfr2+/S252W mice;
S252W unaffected littermates) as an estimate of the
change due to growth from E17.5 to P0. The GM esti-
mates growth for each sample as the relative change in
the lengths of all unique linear distances between land-
marks. Differences in growth between samples are esti-
mated by the growth difference matrix (GDM) consisting
of the element-wise ratios of the GM estimated for mutant
mice to the GM estimated for unaffected littermates.
Elements of the GDM are statistically evaluated using
methods similar to those described above for form using
non-parametric bootstrapping (100,000 resamples) and
confidence interval testing (α = 0.10) [24,29] (Figure 6).
Growth differences were also estimated and statistically
evaluated for anatomical regions [see Additional file 7].
Hypothetical forms
We used EDMA to produce hypothetical forms from 3D
morphological data by applying the GM calculated for a
sample (e.g., growth of Fgfr2+/P253R mice from E17.5 to
P0) to the FM representing the average form from an-
other sample (e.g., FGFR2 P253R unaffected littermates
at E17.5) following [29]. Hypothetical forms are pro-
duced by an element-wise multiplication of the FM of
interest (the E17.5 starting form) by the GM of interest
(the growth trajectory), with both matrices written as
vectors. The resulting matrix representing the morph-
ology of a normal E17.5 individual who has followed the
growth pattern specific to mice carrying an Fgfr2 muta-
tion, is subjected to a spectral decomposition (i.e., prin-
cipal coordinates analysis) to obtain the 3D coordinates
of landmark locations for the hypothetical form [29]. A
check of the dimensionality of the landmark coordinates
stipulates that the sum of the first three eigenvalues
must collectively exceed 95% of the sum of all the eigen-
values validating the hypothetical form as biologically
possible [24,29]. In our examples, the first three eigen-
values of the hypothetical forms constituted >99% of the
sum of the eigenvalues. Hypothetical forms thus pro-
duced can be compared to age-matched samples or ana-
lyzed using ordination methods like PCA (Figure 7) to
identify the groups to which they are most phenotypic-
ally similar. Because the simulated morphologies (Hypo-
thetical forms A and B) and the unaffected mice share
the same initial morphology at E17.5, differences be-
tween the hypothetical forms and unaffected P0 mice
can be attributed exclusively to differences in growth
pattern caused by the presence of an Fgfr2 mutation.
Suture analysis
All sutures were scored using isosurfaces segmented for
bone using hydroxyapatite phantoms imaged with the
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ance of fusion, we examined individual HRμCT slice im-
ages for that portion of the suture to verify fusion. For
each specimen, sutures were scored qualitatively as open
(O) when more than 75% of the length of the suture was
completely patent; partial (P) when more than 25% but
less than 75% of the length of the suture was patent; and
fused (F) when less than 25% of the length of the suture
was patent.Additional files
Additional file 1: Table S1. Anatomical definitions of landmarks
collected from HRμCT isosurfaces and used in analysis.
Additional file 2: Table S2. Results (p-values) of nonparametric null
hypothesis tests for form differences between Fgfr2+/S252W and Fgfr2+/P253R
mutant mice and their respective unaffected littermates at E17.5 and P0.
Additional file 3: Apert252_E17.5_EDMA. Video 1: 3D reconstruction of
isosurface of E17.5 mouse skull showing linear differences in cranial
morphology as measured between 3D coordinates of anatomical landmarks
between Fgfr2+/S252W mice and unaffected littermates when landmarks are
analyzed by EDMA, following Figure 4A and B. Blue lines are significantly
larger in mutant mice relative to unaffected littermates. Fuchsia lines are
significantly smaller in mutant mice. Bone segmented from HRμCT images
is shown as partially transparent to better visualize the growth differences.
Additional file 4: Apert253_E17.5_EDMA. Video 2: 3D reconstruction
of isosurface of E17.5 mouse skull showing linear differences in cranial
morphology as measured between 3D coordinates of anatomical
landmarks between Fgfr2+/P253R mice and unaffected littermates following
Figure 4E and F. Blue lines are significantly larger in mutant mice relative
to unaffected littermates. Fuchsia lines are significantly smaller in mutant
mice. Bone segmented from HRμCT images is shown as partially
transparent to better visualize the growth differences.
Additional file 5: Apert252_P0_EDMA. Video 3: 3D reconstruction of
isosurface of P0 mouse skull showing linear differences in cranial
morphology as measured between 3D coordinates of anatomical landmarks
between Fgfr2+/S252W mice and unaffected littermates when landmarks are
analyzed by EDMA, following Figure 4C and D. Blue lines are significantly
larger in mutant mice relative to unaffected littermates. Fuchsia lines are
significantly smaller in mutant mice. Bone segmented from HRμCT images
is shown as partially transparent to better visualize growth differences.
Additional file 6: Apert253_P0_EDMA.mpg. Video 4: 3D reconstruction
of isosurface of P0 mouse skull showing linear differences in cranial
morphology as measured between 3D coordinates of anatomical landmarks
between Fgfr2+/P253R mice and unaffected littermates following Figure 4G and
H. Blue lines are significantly larger in mutant mice relative to unaffected
littermates. Fuchsia lines are significantly smaller in mutant mice. Bone
segmented from HRμCT images is shown as partially transparent to better
visualize the growth differences.
Additional file 7: Table S3_GDMA_results. Table S3. Results of null
hypothesis testing for differences in growth between Fgfr2+/S252W and
Fgfr2+/P253R mutant mice and unaffected littermates.
Additional file 8: Apert252_GDMA. Video 5: Differences in cranial
growth between E17.5 and P0 as determined by GDMA of 3D landmarks of
Fgfr2+/S252W mice and unaffected littermates following Figure 6A and B.
Linear distances that grew significantly more (blue) and significantly less
(white) in mutant mice are shown on a 3D reconstruction of an isosurface
of an E17.5 mouse skull. Thin lines indicate linear distances that showed
growth magnitudes 5-10% different between mice carrying one of the two
Fgfr2 mutations and their respective unaffected littermates; thick lines indicate
linear distances that showed growth magnitudes >10% different between
unaffected and mutant mice. Bone segmented from HRμCT images is shown
as partially transparent to better visualize the growth differences.Additional file 9: Apert253_GDMA. Video 6: Differences in cranial
growth between E17.5 and P0 as determined by GDMA of 3D landmarks of
Fgfr2+/P253R mice and unaffected littermates following Figure 6C and D. Linear
distances that grew significantly more (blue) and significantly less (white) in
mutant mice are shown on a 3D reconstruction of an isosurface of an E17.5
mouse skull. Thin lines indicate linear distances that showed growth
magnitudes 5-10% different between mice carrying one of the two Fgfr2
mutations and their respective unaffected littermates; thick lines indicate linear
distances that showed growth magnitudes >10% different between
unaffected and mutant mice. Bone segmented from HRμCT images is shown
as partially transparent to better visualize the growth differences.
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